HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,563,066 | -40.1% | 171,808 | -43.5% | 2.26% | -4.6% |
| Q2 2023 | $10,965,605 | -10.7% | 304,009 | -5.4% | 2.37% | -6.7% |
| Q1 2023 | $12,274,839 | -51.5% | 321,415 | -27.7% | 2.54% | -22.5% |
| Q4 2022 | $25,305,023 | +40.5% | 444,728 | -2.4% | 3.27% | +31.7% |
| Q3 2022 | $18,014,000 | +9.8% | 455,583 | +22.2% | 2.48% | +37.0% |
| Q2 2022 | $16,404,000 | +60.6% | 372,818 | +45.5% | 1.81% | +93.5% |
| Q1 2022 | $10,217,000 | – | 256,185 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |